Kyowa Kirin CoKYKOF 82 Days Payable is 307.79 as of Dec. 2025, which is 24% above its 10-year median of 247.51. GuruFocus rates KYKOF with a GF Score™ of 82/100 and a GF Value™ of $17.92 (Modestly Undervalued). The stock has 1 warning sign investors should review. Among 923 Drug Manufacturers companies, Kyowa Kirin Co ranks better than 91.33% on this metric.
The historical rank and industry rank for Kyowa Kirin Co's Days Payable or its related term are showing as below:
KYKOF'
s Days Payable Range Over the Past 10 Years
Min: 97.46 Med: 247.51 Max: 351.07
Current: 307.96
During the past 13 years, Kyowa Kirin Co's highest Days Payable was 351.07. The lowest was 97.46. And the median was 247.51.
KYKOF's Days Payable is ranked better than 91.33% of 923
companies
in the Drug Manufacturers industry
Industry Median: 90.98
vs KYKOF: 307.96
Kyowa Kirin Co's Days Payable
increased
from Dec. 2024 (281.65) to Dec. 2025 (307.79).
It may suggest that Kyowa Kirin Codelayed paying its suppliers.
Kyowa Kirin Co Days Payable Related Terms
Kyowa Kirin Co Days Payable Historical Data
* Premium members only.
The historical data trend for Kyowa Kirin Co's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Kyowa Kirin Co's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Kyowa Kirin Co Days Payable vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Kyowa Kirin Co's Days Payable distribution charts can be found below:
* The bar in red indicates where Kyowa Kirin Co's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Kyowa Kirin Co's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Kyowa Kirin Co (KYKOF) has a Days Payable of 307.79 as of Dec. 2025. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Kyowa Kirin Co and its competitors. This is 24% above median its historical median of 247.51. Over the past decade, Kyowa Kirin Co's Days Payable has ranged from 97.46 to 351.07. According to the industry distribution chart, Kyowa Kirin Co ranks #80 out of 923 companies in the Drug Manufacturers industry, placing it in the top 8.7%.
Is Kyowa Kirin Co's Days Payable too high?
Kyowa Kirin Co's current Days Payable of 307.79 is 24% above median its 10-year median of 247.51. Over the past 10 years, this metric has ranged from a low of 97.46 to a high of 351.07. The Drug Manufacturers industry median Days Payable is 90.98. Kyowa Kirin Co's value of 307.79 is 238.3% above this industry median. Based on the distribution chart, Kyowa Kirin Co ranks #80 out of 923 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Kyowa Kirin Co has a GF Score™ of 82/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Kyowa Kirin Co's Days Payable compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Kyowa Kirin Co ranks #80 out of 923 companies for Days Payable. This places Kyowa Kirin Co in the top 9% of its industry — outperforming the majority of peers. The industry median Days Payable is 90.98. Kyowa Kirin Co's value of 307.79 is 238.3% above this benchmark. Historically, Kyowa Kirin Co's own Days Payable has ranged from 97.46 to 351.07 over the past decade. While the company's 10-year median is 247.51 vs. the industry median of 90.98, Kyowa Kirin Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Drug Manufacturers company?
The median Days Payable among Drug Manufacturers companies is 90.98, based on 923 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Kyowa Kirin Co's current Days Payable of 307.79 is 238.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Kyowa Kirin Co and its competitors. For the Drug Manufacturers industry, the median Days Payable is 90.98 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Kyowa Kirin Co's current Days Payable is 307.79, which is 24% above median its own 10-year median of 247.51. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kyowa Kirin Co stock overvalued right now?
Based on GuruFocus' analysis, Kyowa Kirin Co (KYKOF) is currently considered Modestly Undervalued. The stock's GF Value™ is $17.92, compared to a current price of $14.43 — trading 19.5% below its estimated fair value. The current Days Payable is 307.79, which is 24% above median its 10-year median of 247.51 and 238.3% above the Drug Manufacturers industry median of 90.98. Kyowa Kirin Co's overall GF Score™ is 82/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Kyowa Kirin Co (KYKOF), the current Days Payable is 307.79 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Kyowa Kirin Co (KYKOF) Overvalued in 2026?
Based on GuruFocus' analysis, Kyowa Kirin Co stock appears to be undervalued.
The current stock price of $14.43 is trading 19.5% below its estimated GF Value™ of $17.92.
GuruFocus considers Kyowa Kirin Co to be Modestly Undervalued.
Key valuation signals for KYKOF:
Days Payable: 307.79 (24% above median its 10-year median of 247.51)
GF Value™: $17.92 vs. price of $14.43 (19.5% below fair value)
Industry Position: 238.3% above the Drug Manufacturers median (#80 of 923)
No single metric tells the full story. See the KYKOF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Kyowa Kirin Co Ltd is engaged in research, development, manufacturing, sales, import and export of prescription pharmaceuticals. Its products include KHK4083/AMG 451, rocatinlimab; ziftomenib; OTL-203 KK8398, infigratinib; KHK4951, tivozanib; OTL-201; KK4277; KK2260; KK2269; KK2845; and KK8123.
82GF Score
Get the complete analysis for KYKOF
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
KYKOF has been successfully added to your 
